![](/img/cover-not-exists.png)
Local consolidation therapy (LCT) after first line tyrosine kinase inhibitor (TKI) for patients with EGFR mutant metastatic non-small cell lung cancer (NSCLC)
Elamin, Yasir Y., Gomez, Daniel R., Antonoff, Mara B., Robichaux, Jacqulyne P., Tran, Hai, Shorter, Melissa K., Bohac, Jadi M., Negrao, Marcelo, Le, Xiuning, Rinsurogkawong, Waree, Lewis, Jeff, LacerdLanguage:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2018.09.015
Date:
September, 2018
File:
PDF, 934 KB
english, 2018